Proposed pathophysiological mechanism for the metabolic dysfunction-associated fatty liver disease promoted atherogenesis includes hepatic release of inflammatory cytokines, deranged lipoprotein metabolism, IR, decrease in adiponectin and increase in pro-coagulation factors(29). Here, ADIPOQ is linked to fatty liver disease.